advertisement
Mohamud R 11
Showing records 1 to 11 | Display all abstracts from Mohamud R100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Lambuk L
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Lambuk L; Mohd Lazaldin MA
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Ahmad S; Sadikan MZ
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Ahmad S; Iezhitsa I
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Nordin NA
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Agarwal R
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Kadir R; Nasir NAA
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Uskoković V
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Chen X
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Mohamud R; Mohamud R
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Boer J; Plebanski M; Mohamud R; Mohamud R
Frontiers in immunology 2022; 13: 857812
